دورية أكاديمية
Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at 24 weeks: A Posthoc Analysis from ENLIVEN
العنوان: | Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at 24 weeks: A Posthoc Analysis from ENLIVEN |
---|---|
المؤلفون: | Loomba, Rohit, Sanyal, Arun J., Gottwald, Mildred D., Feng, Shibao, Tseng, Leo, Hartsfield, Cynthia L., Mansbach, Hank, Margalit, Maya, Bhatt, Deepak L. |
المصدر: | In Metabolism June 2024 153 Supplement |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!